The interferon-inducible p200 family of proteins: A perspective on their roles in cell cycle regulation and differentiation

Blood Cells, Molecules, and Diseases

Volumn 32, Issue 1, 2004, Pages 155-167

  Asefa, Benyam ^a   Klarmann, Kimberly D ^a   Copeland, Neal G ^a   Gilbert, Debra J ^a   Jenkins, Nancy A ^a   Keller, Jonathan R ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

Cell cycle regulation; IFN; Interferon inducible p200

Indexed keywords

ABSENT IN MELANOMA PROTEIN; AMINO ACID DERIVATIVE; INTERFERON; M PROTEIN; MYELOID CELL NUCLEAR DIFFERENTIATION ANTIGEN; PROTEIN DERIVATIVE; PROTEIN IFI 16; PROTEIN P200; PROTEIN P202; PROTEIN P203; PROTEIN P204; PROTEIN P205; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER INCIDENCE; CELL ACTIVITY; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; CROSS LINKING; GENE MUTATION; HUMAN; IMMUNOMODULATION; INFLAMMATION; MELANOMA; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

MURINAE;

EID: 0742306871     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2003.10.002     Document Type: Article

References (101)

1. Samanta H., Pravtcheva D.D., Ruddle F.H., Lengyel P. Chromosomal location of mouse gene 202 which is induced by interferons and specifies a 56.5 kD protein. J. Interferon. Res. 4(2):1984;295-300.
2. Wang H., Chatterjee G., Meyer J.J., Liu C.J., Manjunath N.A., Bray-Ward P., Lengyel P. Characteristics of three homologous 202 genes (Ifi202a, Ifi202b, and Ifi202c) from the murine interferon-activatable gene 200 cluster. Genomics. 60(3):1999;281-294.
3. Gribaudo G., Ravaglia S., Guandalini L., Riera L., Gariglio M., Landolfo S. Molecular cloning and expression of an interferon-inducible protein encoded by gene 203 from the gene 200 cluster. Eur. J. Biochem. 249(1):1997;258-264.
4. Choubey D., Lengyel P. Interferon action: nucleolar and nucleoplasmic localization of the interferon-inducible 72-kD protein that is encoded by the Ifi 204 gene from the gene 200 cluster. J. Cell Biol. 116(6):1992;1333-1341.
5. Tannenbaum C.S., Major J., Ohmori Y., Hamilton T.A. A lipopolysaccharide-inducible macrophage gene (D3) is a new member of an interferon-inducible gene cluster and is selectively expressed in mononuclear phagocytes. J. Leukocyte Biol. 53(5):1993;563-568.
6. Trapani J.A., Browne K.A., Dawson M.J., Ramsay R.G., Eddy R.L., Show T.B., White P.C., Dupont B. A novel gene constitutively expressed in human lymphoid cells is inducible with interferon-gamma in myeloid cells. Immunogenetics. 36(6):1992;369-376.
7. Briggs J.A., Burrus G.R., Stickney B.D., Briggs R.C. Cloning and expression of the human myeloid cell nuclear differentiation antigen: regulation by interferon alpha. J. Cell. Biochem. 49(1):1992;82-92.
8. DeYoung K.L., Ray M.E., Su Y.A., Anzick S.L., Johnstone R.W., Trapani J.A., Meltzer P.S., Trent J.M. Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma. Oncogene. 15(4):1997;453-457.
9. Dawson M.J., Trapani J.A. HIN-200: a novel family of IFN-inducible nuclear proteins expressed in leukocytes. J. Leukocyte Biol. 60(3):1996;310-316.
10. Landolfo S., Gariglio M., Gribaudo G., Lembo D. The Ifi 200 genes: an emerging family of IFN-inducible genes. Biochimie. 80(8-9):1998;721-728.
11. Lengyel P. Tumor-suppressor genes: news about the interferon connection. Proc. Natl. Acad. Sci. U. S. A. 90(13):1993;5893-5895.
12. Johnstone R.W., Trapani J.A. Transcription and growth regulatory functions of the HIN-200 family of proteins. Mol. Cell. Biol. 19(9):1999;5833-5838.
13. Choubey D., Walter S., Geng Y., Xin H. Cytoplasmic localization of the interferon-inducible protein that is encoded by the AIM2 (absent in melanoma) gene from the 200-gene family. FEBS Lett. 474(1):2000;38-42.
14. Choubey D., Snoddy J., Chaturvedi V., Toniato E., Opdenakker G., Thakur A., Samanta H., Engel D.A., Lengyel P. Interferons as gene activators. Indications for repeated gene duplication during the evolution of a cluster of interferon-activatable genes on murine chromosome 1. J. Biol. Chem. 264(29):1989;17182-17189.
15. Datta B., Li B., Choubey D., Nallur G., Lengyel P. p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition. J. Biol. Chem. 271(44):1996;27544-27555.
16. Koul D., Obeyesekere N.U., Gutterman J.U., Mills G.B., Choubey D. p202 self-associates through a sequence conserved among the members of the 200-family proteins. FEBS Lett. 438(1-2):1998;21-24.
17. Staub E., Dahl E., Rosenthal A. The DAPIN family: a novel domain links apoptotic and interferon response proteins. Trends Biochem. Sci. 26(2):2001;83-85.
18. Opdenakker G., Snoddy J., Choubey D., Toniato E., Pravtcheva D.D., Seldin M.F., Ruddle F.H., Lengyel P. Interferons as gene activators: a cluster of six interferon-activatable genes is linked to the erythroid alpha-spectrin locus on murine chromosome 1. Virology. 171(2):1989;568-578.
19. Choubey D., Lengyel P. Interferon action: cytoplasmic and nuclear localization of the interferon-inducible 52-kD protein that is encoded by the Ifi 200 gene from the gene 200 cluster. J. Interferon. Res. 13(1):1993;43-52.
20. Engel D.A., Samanta H., Brawner M.E., Lengyel P. Interferon action: transcriptional control of a gene specifying a 56,000-Da protein in Ehrlich ascites tumor cells. Virology. 142(2):1985;389-397.
21. Gariglio M., Cinato E., Panico S., Cavallo G., Landolfo S. Activation of interferon-inducible genes in mice by poly rI:rC or alloantigens. J. Immunother. 10(1):1991;20-27.
22. Min W., Ghosh S., Lengyel P. The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kappa B, c-Fos, and c-Jun activities. Mol. Cell. Biol. 16(1):1996;359-368.
23. Choubey D. P202: an interferon-inducible negative regulator of cell growth. J. Biol. Regul. Homeostatic Agents. 14(3):2000;187-192.
24. Datta B., Min W., Burma S., Lengyel P. Increase in p202 expression during skeletal muscle differentiation: inhibition of MyoD protein expression and activity by p202. Mol. Cell. Biol. 18(2):1998;1074-1083.
25. Wang H., Ding B., Liu C.J., Ma X.Y., Deschamps S., Roe B.A., Lengyel P. The increase in levels of interferon-inducible proteins p202a and p202b and RNA-dependent protein kinase (PKR) during myoblast differentiation is due to transactivation by MyoD: their tissue distribution in uninfected mice does not depend on interferons. J. Interferon Cytokine Res. 22(6):2002;729-737.
26. Lembo D., Angeretti A., Benefazio S., Hertel L., Gariglio M., Novelli F., Landolfo S. Constitutive expression of the interferon-inducible protein p202 in NIH 3T3 cells affects cell cycle progression. J. Biol. Regul. Homeostatic Agents. 9(2):1995;42-46.
27. Yan D.H., Wen Y., Spohn B., Choubey D., Gutterman J.U., Hung M.C. Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202. Oncogene. 18(3):1999;807-811.
28. Wen Y., Yan D.H., Spohn B., Deng J., Lin S.Y., Hung M.C. Tumor suppression and sensitization to tumor necrosis factor alpha-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cells. Cancer Res. 60(1):2000;42-46.
29. Choubey D., Lengyel P. Binding of an interferon-inducible protein (p202) to the retinoblastoma protein. J. Biol. Chem. 270(11):1995;6134-6140.
30. Choubey D., Gutterman J.U. Inhibition of E2F-4/DP-1-stimulated transcription by p202. Oncogene. 15(3):1997;291-301.
31. Choubey D., Li S.J., Datta B., Gutterman J.U., Lengyel P. Inhibition of E2F-mediated transcription by p202. EMBO J. 15(20):1996;5668-5678.
32. Wang H., Liu C., Lu Y., Chatterjee G., Ma X.Y., Eisenman R.N., Lengyel P. The interferon- and differentiation-inducible p202a protein inhibits the transcriptional activity of c-Myc by blocking its association with Max. J. Biol. Chem. 275(35):2000;27377-27385.
33. Gutterman J.U., Choubey D. Retardation of cell proliferation after expression of p202 accompanies an increase in p21(WAF1/CIP1). Cell Growth Differ. 10(2):1999;93-100.
34. Xin H., D'Souza S., Fang L., Lengyel P., Choubey D. p202, an interferon-inducible negative regulator of cell growth, is a target of the adenovirus E1A protein. Oncogene. 20(47):2001;6828-6839.
35. Koul D., Lapushin R., Xu H.J., Mills G.B., Gutterman J.U., Choubey D. p202 prevents apoptosis in murine AKR-2B fibroblasts. Biochem. Biophys. Res. Commun. 247(2):1998;379-382.
36. Yan D.H., Abramian A., Li Z., Ding Y., Wen Y., Liu T.J., Hunt K. p202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells. Biochem. Biophys. Res. Commun. 303(1):2003;219-222.
37. Colman M.S., Afshari C.A., Barrett J.C. Regulation of p53 stability and activity in response to genotoxic stress. Mutat. Res. 462(2-3):2000;179-188.
38. D'Souza S., Xin H., Walter S., Choubey D. The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression. J. Biol. Chem. 276(1):2001;298-305.
39. Geng Y., Choubey D. Differential induction of the 200-family proteins in Daudi Burkitt's lymphoma cells by interferon-alpha. J. Biol. Regul. Homeostatic Agents. 14(4):2000;263-268.
40. Iwabuchi K., Li B., Massa H.F., Trask B.J., Date T., Fields S. Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2. J. Biol. Chem. 273(40):1998;26061-26068.
41. Gribaudo G., Riera L., Hertel L., Landolfo S. In vitro and in vivo expression analysis of the interferon-inducible 203 gene. J. Interferon Cytokine Res. 19(2):1999;129-136.
42. Gribaudo G., Riera L., De Andrea M., Landolfo S. The antiproliferative activity of the murine interferon-inducible Ifi 200 proteins depends on the presence of two 200 amino acid domains. FEBS Lett. 456(1):1999;31-36.
43. Deschamps S., Meyer J., Chatterjee G., Wang H., Lengyel P., Roe B.A. The mouse Ifi200 gene cluster: genomic sequence, analysis, and comparison with the human HIN-200 gene cluster. Genomics. 82(1):2003;34-46.
44. Gariglio M., De Andrea M., Lembo M., Ravotto M., Zappador C., Valente G., Landolfo S. The murine homolog of the HIN 200 family, Ifi 204, is constitutively expressed in myeloid cells and selectively induced in the monocyte/macrophage lineage. J. Leukocyte Biol. 64(5):1998;608-614.
45. Liu C., Wang H., Zhao Z., Yu S., Lu Y.B., Meyer J., Chatterjee G., Deschamps S., Roe B.A., Lengyel P. MyoD-dependent induction during myoblast differentiation of p204, a protein also inducible by interferon. Mol. Cell. Biol. 20(18):2000;7024-7036.
46. Liu C.J., Ding B., Wang H., Lengyel P. The MyoD-inducible p204 protein overcomes the inhibition of myoblast differentiation by Id proteins. Mol. Cell. Biol. 22(9):2002;2893-2905.
47. Deftos M.L., Huang E., Ojala E.W., Forbush K.A., Bevan M.J. Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes. Immunity. 13(1):2000;73-84.
48. De Andrea M., Zannetti C., Noris E., Gariglio M., Azzimonti B., Landolfo S. The mouse interferon-inducible gene ifi204 product interacts with the tpr protein, a component of the nuclear pore complex. J. Interferon Cytokine Res. 22(11):2002;1113-1121.
49. Lembo M., Sacchi C., Zappador C., Bellomo G., Gaboli M., Pandolfi P.P., Gariglio M., Landolfo S. Inhibition of cell proliferation by the interferon-inducible 204 gene, a member of the Ifi 200 cluster. Oncogene. 16(12):1998;1543-1551.
50. Hertel L., Rolle S., De Andrea M., Azzimonti B., Osello R., Gribaudo G., Gariglio M., Landolfo S. The retinoblastoma protein is an essential mediator that links the interferon-inducible 204 gene to cell-cycle regulation. Oncogene. 19(32):2000;3598-3608.
51. De Andrea M., Ravotto M., Noris E., Ying G.G., Gioia D., Azzimonti B., Gariglio M., Landolfo S. The interferon-inducible gene, Ifi204, acquires malignant transformation capability upon mutation at the Rb-binding sites. FEBS Lett. 515(1-3):2002;51-57.
52. Liu C.J., Wang H., Lengyel P. The interferon-inducible nucleolar p204 protein binds the ribosomal RNA-specific UBF1 transcription factor and inhibits ribosomal RNA transcription. EMBO J. 18(10):1999;2845-2854.
53. Tannenbaum C.S., Koerner T.J., Jansen M.M., Hamilton T.A. Characterization of lipopolysaccharide-induced macrophage gene expression. J. Immunol. 140(10):1988;3640-3645.
54. Hamilton T.A., Bredon N., Ohmori Y., Tannenbaum C.S. IFN-gamma and IFN-beta independently stimulate the expression of lipopolysaccharide-inducible genes in murine peritoneal macrophages. J. Immunol. 142(7):1989;2325-2331.
55. Weiler S.R., Gooya J.M., Ortiz M., Tsai S., Collins S.J., Keller J.R. D3: a gene induced during myeloid cell differentiation of Linlo c-Kit+ Sca-1(+) progenitor cells. Blood. 93(2):1999;527-536.
56. Trapani J.A., Dawson M., Apostolidis V.A., Browne K.A. Genomic organization of IFI16, an interferon-inducible gene whose expression is associated with human myeloid cell differentiation: correlation of predicted protein domains with exon organization. Immunogenetics. 40(6):1994;415-424.
57. Dawson M.J., Trapani J.A. IFI 16 gene encodes a nuclear protein whose expression is induced by interferons in human myeloid leukaemia cell lines. J. Cell. Biochem. 57(1):1995;39-51.
58. Dawson M.J., Trapani J.A. The interferon-inducible autoantigen, IFI 16: localization to the nucleolus and identification of a DNA-binding domain. Biochem. Biophys. Res. Commun. 214(1):1995;152-162.
59. Dawson M.J., Elwood N.J., Johnstone R.W., Trapani J.A. The IFN-inducible nucleoprotein IFI 16 is expressed in cells of the monocyte lineage, but is rapidly and markedly down-regulated in other myeloid precursor populations. J. Leukocyte Biol. 64(4):1998;546-554.
60. Clarke C.J., Apostolidis V., Hii L.L., Gough D.J., Trapani J.A., Johnstone R.W. Critical role of the transcription factor AP-1 for the constitutive and interferon-induced expression of IFI 16. J. Cell. Biochem. 89(1):2003;80-93.
61. Xin H., Curry J., Johnstone R.W., Nickoloff B.J., Choubey D. Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence. Oncogene. 22(31):2003;4831-4840.
62. Magnaghi-Jaulin L., Groisman R., Naguibneva I., Robin P., Lorain S., Le Villain J.P., Troalen F., Trouche D., Harel-Bellan A. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature. 391(6667):1998;601-605.
63. Johnstone R.W., Kerry J.A., Trapani J.A. The human interferon-inducible protein, IFI 16, is a repressor of transcription. J. Biol. Chem. 273(27):1998;17172-17177.
64. Lengyel P.C.D., Li S.J., Datta B. The interferon-activatable gene 200 cluster: from structure toward function. Semin. Virol. 6(3):1995;203-213.
65. Johnstone R.W., Kershaw M.H., Trapani J.A. Isotypic variants of the interferon-inducible transcriptional repressor IFI 16 arise through differential mRNA splicing. Biochemistry. 37(34):1998;11924-11931.
66. Johnstone R.W., Wei W., Greenway A., Trapani J.A. Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16. Oncogene. 19(52):2000;6033-6042.
67. Kwak J.C., Ongusaha P.P., Ouchi T., Lee S.W. IFI16 as a negative regulator in the regulation of p53 and p21. J. Biol. Chem. 2003.
68. Cuddihy A.R., Li S., Tam N.W., Wong A.H., Taya Y., Abraham N., Bell J.C., Koromilas A.E. Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53. Mol. Cell. Biol. 19(4):1999;2475-2484.
69. Hupp T.R., Meek D.W., Midgley C.A., Lane D.P. Activation of the cryptic DNA binding function of mutant forms of p53. Nucleic Acids Res. 21(14):1993;3167-3174.
70. Arany I., Brysk M.M., Calhoun K.H., Tyring S.K. Differentiation and IFN gamma regulate WAF1/CIP1 transcription in p53-independent and p53-dependent pathways in epithelial cells. In Vivo. 10(1):1996;119-123.
71. Subramaniam P.S., Johnson H.M. A role for the cyclin-dependent kinase inhibitor p21 in the G1 cell cycle arrest mediated by the type I interferons. J. Interferon Cytokine Res. 17(1):1997;11-15.
72. Hobeika A.C., Etienne W., Torres B.A., Johnson H.M., Subramaniam P.S. IFN-gamma induction of p21(WAF1) is required for cell cycle inhibition and suppression of apoptosis. J. Interferon Cytokine Res. 19(12):1999;1351-1361.
73. Cousar J.B., Briggs R.C. Expression of human myeloid cell nuclear differentiation antigen (MNDA) in acute leukemias. Leuk. Res. 14(10):1990;915-920.
74. Briggs R., Dworkin L., Briggs J., Dessypris E., Stein J., Stein G., Lian J. Interferon alpha selectively affects expression of the human myeloid cell nuclear differentiation antigen in late stage cells in the monocytic but not the granulocytic lineage. J. Cell. Biochem. 54(2):1994;198-206.
75. Goldberger A., Brewer G., Hnilica L.S., Briggs R.C. Nonhistone protein antigen profiles of five leukemic cell lines reflect the extent of myeloid differentiation. Blood. 63(3):1984;701-710.
76. Goldberger A., Hnilica L.S., Casey S.B., Briggs R.C. Properties of a nuclear protein marker of human myeloid cell differentiation. J. Biol. Chem. 261(10):1986;4726-4731.
77. Xie J., Briggs J.A., Briggs R.C. MNDA dimerizes through a complex motif involving an N-terminal basic region. FEBS Lett. 408(2):1997;151-155.
78. Xie J., Briggs J.A., Olson M.O., Sipos K., Briggs R.C. Human myeloid cell nuclear differentiation antigen binds specifically to nucleolin. J. Cell. Biochem. 59(4):1995;529-536.
79. Xie J., Briggs J.A., Morris S.W., Olson M.O., Kinney M.C., Briggs R.C. MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia. Exp. Hematol. 25(11):1997;1111-1117.
80. Xie J., Briggs J.A., Briggs R.C. Human hematopoietic cell specific nuclear protein MNDA interacts with the multifunctional transcription factor YY1 and stimulates YY1 DNA binding. J. Cell. Biochem. 70(4):1998;489-506.
81. Kao W.Y., Briggs J.A., Kinney M.C., Jensen R.A., Briggs R.C. Structure and function analysis of the human myeloid cell nuclear differentiation antigen promoter: evidence for the role of Sp1 and not of c-Myb or PU.1 in myelomonocytic lineage-specific expression. J. Cell. Biochem. 65(2):1997;231-244.
82. Kao W.Y., Dworkin L.L., Briggs J.A., Briggs R.C. Characterization of the human myeloid cell nuclear differentiation antigen gene promoter. Biochim. Biophys. Acta. 1308(3):1996;201-204.
83. Doggett K.L., Briggs J.A., Linton M.F., Fazio S., Head D.R., Xie J., Hashimoto Y., Laborda J., Briggs R.C. Retroviral mediated expression of the human myeloid nuclear antigen in a null cell line upregulates Dlk1 expression. J. Cell. Biochem. 86(1):2002;56-66.
84. Miranda R.N., Briggs R.C., Shults K., Kinney M.C., Jensen R.A., Cousar J.B. Immunocytochemical analysis of MNDA in tissue sections and sorted normal bone marrow cells documents expression only in maturing normal and neoplastic myelomonocytic cells and a subset of normal and neoplastic B lymphocytes. Hum. Pathol. 30(9):1999;1040-1049.
85. Mori Y., Yin J., Rashid A., Leggett B.A., Young J., Simms L., Kuehl P.M., Langenberg P., Meltzer S.J., Stine O.C. Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability. Cancer Res. 61(16):2001;6046-6049.
86. Kulaeva O.I., Draghici S., Tang L., Kraniak J.M., Land S.J., Tainsky M.A. Epigenetic silencing of multiple interferon pathway genes after cellular immortalization. Oncogene. 22(26):2003;4118-4127.
87. Varambally S., Dhanasekaran S.M., Zhou M., Barrette T.R., Kumar-Sinha C., Sanda M.G., Ghosh D., Pienta K.J., Sewalt R.G., Otte A.P., Rubin M.A., Chinnaiyan A.M. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 419(6907):2002;624-629.
88. Certa U., Seiler M., Padovan E., Spagnoli G.C. High density oligonucleotide array analysis of interferon-alpha2a sensitivity and transcriptional response in melanoma cells. Br. J. Cancer. 85(1):2001;107-114.
89. Certa U., Seiler M., Padovan E., Spagnoli G.C. Interferon-a sensitivity in melanoma cells: detection of potential response marker genes. Recent Results Cancer Res. 160:2002;85-91.
90. Morel L., Blenman K.R., Croker B.P., Wakeland E.K. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc. Natl. Acad. Sci. U. S. A. 98(4):2001;1787- 1792.
91. Tsao B.P. Lupus susceptibility genes on human chromosome 1. Int. Rev. Immunol. 19(4-5):2000;319-334.
92. Seelig H.P., Ehrfeld H., Renz M. Interferon-gamma-inducible protein p16. A new target of antinuclear antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 37(11):1994;1672-1683.
93. Rozzo S.J., Allard J.D., Choubey D., Vyse T.J., Izui S., Peltz G., Kotzin B.L. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity. 15(3):2001;435-443.
94. Fiorentino L., Stehlik C., Oliveira V., Ariza M.E., Godzik A., Reed J.C. A novel PAAD-containing protein that modulates NF-kappa B induction by cytokines tumor necrosis factor-alpha and interleukin-1beta. J. Biol. Chem. 277(38):2002;35333-35340.
95. Gozani O., Boyce M., Yoo L., Karuman P., Yuan J. Life and death in paradise. Nat. Cell Biol. 4(6):2002;E159-E162.
96. Pawlowski K., Pio F., Chu Z., Reed J.C., Godzik A. PAAD - A new protein domain associated with apoptosis, cancer and autoimmune diseases. Trends Biochem. Sci. 26(2):2001;85-87.
97. Stehlik C., Fiorentino L., Dorfleutner A., Bruey J.M., Ariza E.M., Sagara J., Reed J.C. The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathways. J. Exp. Med. 196(12):2002;1605-1615.
98. Stehlik C., Krajewska M., Welsh K., Krajewski S., Godzik A., Reed J.C. The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated NF-kB and pro-Caspase-1 regulation. Biochem. J. 2003;26.
99. Orbach H., Ben-Chetrit E. Familial Mediterranean fever - A review and update. Minerva Med. 92(6):2001;421-430.
100. Pras M. Familial Mediterranean fever: from the clinical syndrome to the cloning of the pyrin gene. Scand. J. Rheumatol. 27(2):1998;92-97.
101. Choubey D., Gutterman J.U. The interferon-inducible growth-inhibitory p202 protein: DNA binding properties and identification of a DNA binding domain. Biochem. Biophys. Res. Commun. 221(2):1996;396-401.